Article
Prognostic prediction of a 12‑methylation gene‑based risk score system on pancreatic adenocarcinoma
27 Apr 2020
Abstract excerpt
Pancreatic adenocarcinoma (PAAD) accounts for ~85% of all pancreatic cancer cases and is associated with a less favorable prognosis. Aberrant DNA methylation may influence the progression of PAAD by inducing abnormal gene expression. Methylation data of PAAD samples with prognosis information were obtained from The Cancer Genome Atlas (training set) and European Bioinformatics Institute Array Express databases...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
